Healthcare provider profile · identity verified

Robert P Blankfield, MD

Family Practice · CLEVELAND, OH · NPI 1245339175

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	919	227
Amlodipine Besylate	Amlodipine Besylate	556	137
Lisinopril	Lisinopril	521	127
Levothyroxine Sodium	Levothyroxine Sodium	371	77
Hydrochlorothiazide	Hydrochlorothiazide	277	63
Irbesartan	Irbesartan	264	65
Rosuvastatin Calcium	Rosuvastatin Calcium	231	57
Metoprolol Succinate	Metoprolol Succinate	198	54
Omeprazole	Omeprazole	195	47
Losartan Potassium	Losartan Potassium	194	53
Metformin Hcl	Metformin Hcl	170	49
Tramadol Hcl	Tramadol Hcl	153	32
Pantoprazole Sodium	Pantoprazole Sodium	149	34
Metoprolol Tartrate	Metoprolol Tartrate	148	36
Glimepiride	Glimepiride	146	41
Famotidine	Famotidine	145	36
Tamsulosin Hcl	Tamsulosin Hcl	144	36
Doxazosin Mesylate	Doxazosin Mesylate	143	38
Ezetimibe	Ezetimibe	142	42
Eliquis	Apixaban	128	23
Allopurinol	Allopurinol	126	32
Fluticasone Propionate	Fluticasone Propionate	126	46
Spironolactone	Spironolactone	124	35
Duloxetine Hcl	Duloxetine Hcl	121	29
Simvastatin	Simvastatin	117	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	114	28
Albuterol Sulfate Hfa	Albuterol Sulfate	106	32
Gabapentin	Gabapentin	103	26
Clopidogrel	Clopidogrel Bisulfate	102	21
Montelukast Sodium	Montelukast Sodium	93	29
Trazodone Hcl	Trazodone Hcl	85	26
Valsartan	Valsartan	85	21
Zolpidem Tartrate	Zolpidem Tartrate	85	12
Atenolol	Atenolol	84	19
Furosemide	Furosemide	81	25
Metformin Hcl Er	Metformin Hcl	80	21
Potassium Chloride	Potassium Chloride	75	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	75	20
Mirtazapine	Mirtazapine	72	18
Donepezil Hcl	Donepezil Hcl	69	20
Triamcinolone Acetonide	Triamcinolone Acetonide	68	35
Sertraline Hcl	Sertraline Hcl	67	16
Lorazepam	Lorazepam	64	12
Alendronate Sodium	Alendronate Sodium	58	15
Myrbetriq	Mirabegron	58	12
Baclofen	Baclofen	54	22
Escitalopram Oxalate	Escitalopram Oxalate	52	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	52	13
Alprazolam	Alprazolam	51	suppressed
Jardiance	Empagliflozin	50	suppressed
Carvedilol	Carvedilol	49	13
Farxiga	Dapagliflozin Propanediol	48	suppressed
Celecoxib	Celecoxib	43	16
Fluoxetine Hcl	Fluoxetine Hcl	43	11
Citalopram Hbr	Citalopram Hydrobromide	42	13
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	41	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	40	suppressed
Bupropion Xl	Bupropion Hcl	37	suppressed
Benazepril Hcl	Benazepril Hcl	35	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	35	suppressed
Finasteride	Finasteride	33	suppressed
Pregabalin	Pregabalin	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	suppressed
Prednisone	Prednisone	31	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	12
Ozempic	Semaglutide	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	11
Januvia	Sitagliptin Phosphate	29	suppressed
Xarelto	Rivaroxaban	27	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	22
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	19
Pravastatin Sodium	Pravastatin Sodium	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	19
Ramipril	Ramipril	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Trimethoprim	Trimethoprim	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	20	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Meloxicam	Meloxicam	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Cephalexin	Cephalexin	18	15
Clonidine Hcl	Clonidine Hcl	18	suppressed
Jantoven	Warfarin Sodium	18	suppressed
Methadone Hcl	Methadone Hcl	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Rizatriptan	Rizatriptan Benzoate	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Colchicine	Colchicine	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Torsemide	Torsemide	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Trospium Chloride	Trospium Chloride	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Digoxin	Digoxin	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Hydrocortisone	Hydrocortisone	13	11
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Leflunomide	Leflunomide	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Acetazolamide	Acetazolamide	12	suppressed
Desipramine Hcl	Desipramine Hcl	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Klor-Con M10	Potassium Chloride	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Econazole Nitrate	Econazole Nitrate	11	suppressed
Glipizide	Glipizide	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error